医药市场研究

医药市场研究

SIS 国际市场研究与战略

健康和保健是生活的重要部分。  

These sectors relate to the development, manufacture, and marketing of medicines.  The global revenue of the pharmaceutical industry is more than $1 trillion. Almost half of this figure comes from two countries: the US and Canada. It is by far the most profitable industry of all. The primary and generic pharmaceutical companies lead the way in the industry.

行业中的一些突破来自专业制药公司。其中一些公司的员工数量比大型公司的一个部门还少。这些小公司对患者产生了巨大影响。他们专注于治疗领域和利基市场。这些公司展示了如何通过有针对性的方法取得成果。一些公司专注于一种疾病。其他公司治疗的疾病只影响少数人群。

美国医药市场在全球占据主导地位。美国是医学研发领域的创新者和推动者。他们的研发成果使国际制药业受益。尽管如此,影响美国患者的主要疾病之一是糖尿病。肿瘤学和自身免疫性疾病也是美国研究的重点。辉瑞、强生和默克公司是美国市场上最大的公司。

医药市场趋势

Public Relations (PR) and Advertising are powerful for Pharma companies.  One of the most prominent is the consumer as customer. Biotech stories are starting to proliferate. One such story involves the use of gene therapy to regrow the skin of a little boy.  As drugs get personalized, stories such as these are capturing imaginations. They are also piquing people’s interest in the sector.  

Patient stories can be powerful.  Negative publicity can also be influential.  One pharma company made headline news for charging $1,000 per day to treat hepatitis, creating a slew of negative publicity.  It’s a brave – and complex new world for biotech and pharmaceutical companies.

There are several challenges in the pharmaceutical industry. These include policy reforms. For example, healthcare officials are likely to overhaul the Affordable Care Act soon. Another problem is the impact of new technologies. Industry players are still doubtful about the effects of these technologies. It is unclear how they will affect drug development and commercialization.  Gene therapy and Gene editing are also gaining more headlines on opportunities and challenges in those sectors.

全球制药机会

Pharmaceutical sales are the largest in the US and Europe. Developed markets for pharmaceuticals comprise the United States and Western Europe. Canada, Japan, and Australia are also part of this market.  The United States sells approximately 33%, Western Europe, 22%, and China, 10%. Japan accounts for 9% Latin America, 7%, and Russia, 4%. South Korea, India, Indonesia, and Australia are below 3%. 

医药影响力营销

One of the digital trends in pharma is influencer marketing. An influencer is one who is active in one or more of the social channels, with a large follower base. Pharma companies have been using influencers. These influencers have been reporting on their use of certain drugs and devices. They are also influencing people’s behavior in the area of disease prevention. Influencers can also encourage adherence to treatment protocols.  Support groups can be highly influential in treatment and patient behavior.

人口老龄化

制药业增长的动力之一是美国和大多数发达经济体的人口老龄化。另一个增长因素是生活方式不健康的人数增加。这些不良选择包括缺乏日常锻炼和不健康的饮食习惯。

美国和欧洲在药物开发和使用方面处于领先地位。印度和中国等其他地区近年来生命科学市场也出现了增长。这种增长的原因是设备和产品需求的不断增长。这也是因为存在大量资本机会。 

医药市场研究解决方案

SIS International Research has over 40+ years of experience in Market Research and Strategy Consulting in the Pharmaceutical industry.  We conduct research with patients, caretakers, physicians, payors, influencers, regulators, and other stakeholders.

我们提供:

  • 焦点小组
  • 在线洞察社区
  • 深度访谈
  • 在线调查
  • 跨国及国际市场研究
  • Market Entry, Sizing, and Opportunity
  • 战略与竞争分析

作者照片

露丝-斯坦纳特

SIS 国际研究与战略创始人兼首席执行官。她在战略规划和全球市场情报方面拥有 40 多年的专业知识,是帮助组织取得国际成功的值得信赖的全球领导者。

满怀信心地拓展全球业务。立即联系 SIS International!

与专家交谈